Financials data is unavailable for this security.
Cash flow in CNYView more
In 2023, 3D Medicines Inc did not generate a significant amount of cash. Cash Flow from Financing totalled 304.51m or 47.96% of revenues. In addition the company used 144.41m for operations while cash used for investing totalled 187.58m.
Cash flow per share | -1.67 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.62 |
---|---|
Tangible book value per share | 3.62 |
More ▼
Balance sheet in CNYView more
Current ratio | 2.58 |
---|---|
Quick ratio | 2.56 |
Total debt/total equity | 0.3066 |
---|---|
Total debt/total capital | 0.2517 |
More ▼